CTMX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against CytomX Therapeutics, Inc. and Lead Plaintiff Deadline: July 20, 2020Business Wire • 07/14/20
MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 07/14/20
7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CytomX Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 07/13/20
ROSEN, A LONGSTANDING AND TOP RANKED FIRM, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action - CTMXPRNewsWire • 07/10/20
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action - CTMXPRNewsWire • 07/07/20
Shareholder Alert: Robbins LLP Reminds Investors CytomX Therapeutics, Inc. (CTMX) Sued for Misleading ShareholdersBusiness Wire • 07/01/20
CTMX Investor Update: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against CytomX Therapeutics, Inc. and Encourages Shareholders to Contact the FirmNewsfile Corp • 06/30/20
CytomX Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The FirmNewsfile Corp • 06/29/20
ROSEN, NATIONAL INVESTOR COUNSEL, Reminds CytomX Therapeutics, Inc. Investors of Important Deadline in Securities Class Action – CTMXBusiness Wire • 06/26/20
CytomX Therapeutics (CTMX) Moves to Buy: Rationale Behind the UpgradeZacks Investment Research • 06/26/20
Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The Firm.Newsfile Corp • 06/26/20
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CytomX Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - CTMXPRNewsWire • 06/24/20
ROSEN, A LEADING NATIONAL FIRM, Reminds CytomX Therapeutics, Inc. Investors of Important July 20 Deadline in Securities Class Action - CTMXPRNewsWire • 06/22/20
Lead Plaintiff Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In CytomX Therapeutics, Inc. To Contact The FirmNewsfile Corp • 06/22/20
CytomX Therapeutics Announces Preclinical Data from Anti-CTLA-4 Probody Therapeutic Programs Presented by Partner Bristol Myers Squibb at AACR Annual MeetingGlobeNewsWire • 06/22/20
Is CytomX Therapeutics (CTMX) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 06/18/20
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Reminds CytomX Therapeutics, Inc. Investors of Important July 20 Deadline in Securities Class Action - CTMXPRNewsWire • 06/05/20
CytomX Therapeutics Clinical Programs Highlighted at American Society of Clinical Oncology ASCO20 Virtual Scientific ProgramGlobeNewsWire • 05/29/20
CTMX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against CytomX Therapeutics, Inc. and Encourages Investors to Contact the FirmPRNewsWire • 05/22/20
CYTOMX LOSS ALERT, ROSEN, A TOP RANKED INVESTOR FIRM, Announces Filing of Securities Class Action Lawsuit Against CytomX Therapeutics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm - CTMXPRNewsWire • 05/22/20
CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/10/20
